Robotic VR System to Teleoperate Robots for Performing COVID-19 Swab Tests
By LabMedica International staff writers Posted on 23 Feb 2022 |

A newly-developed robotic virtual reality (VR) human-machine interface (HMI) system can teleoperate the robot to imitate the user's actions to perform complicated tasks such as COVID-19 swab tests.
A research team co-led by City University of Hong Kong (CityU Hong Kong) has developed an innovative HMI system, which consists of flexible, multi-layered electronic skin and provides both visual and haptic feedback to users. The system can teleoperate the robot to imitate the user's actions to perform complicated tasks. It demonstrates the potential for conducting COVID-19 swab tests and nursing patients with infectious diseases.
The HMI system links users to robotics or computers and plays a significant role in teleoperating robotics. However, conventional HMIs are based on bulky, rigid and expensive machines, and the lack of adequate feedback to users limits their application for conducting complicated tasks. The closed-loop HMI system is based on soft, skin-integrated electronics, which enable wireless motion capture and haptic feedback via Bluetooth, Wi-Fi and the internet.
The advanced HMI system, named Robotic VR, is an integration of visual, auditory and haptic VR via skin-integrated electronics. It uses a layout of multilayer stacking, where the bottom layer of skin-tone elastomeric silicon serves as a soft adhesive interface, which can be mounted on the skin and joints of the user. The layers are interconnected with a collection of chip-scale integrated circuits and sensing components, including resistors, capacitors, a Bluetooth module, a microcontroller unit (MCU), and soft sensors and actuators developed by the team.
The sensors of the robotic VR system can accurately detect and convert subtle human motion into electrical signals, which are processed by the MCU and wirelessly transmitted to the target robot. In this way, the user can teleoperate the robot to imitate his motion to accomplish tasks remotely. The pressure sensors on the robot can send feedback signals to control the vibration intensity of the haptic actuators through the Bluetooth module, thus providing haptic feedback to the user. The user can then precisely control and adjust the motion of the robot’s arm according to the intensity of the feedback.
The HMI system supports three wireless transmission methods – Bluetooth (up to tens of meters), Wi-Fi (up to about 100 meters), and the Internet (worldwide) – which can be adjusted according to the practical applications. The new system is stretchable and can be tightly mounted on human skin and even the whole human body for a long time. In addition, the interface provides both haptic and visual feedback systems, providing an immersive experience for users. The HMIs could teleoperate various machines. With the advanced circuit design and outstanding mechanical characteristics, the newly invented HMI system has great potential for applications in commercial and biomedical engineering fields. For example, it can be used to remotely drive unmanned cars. A user with a hand disability can remotely manipulate a robot to carry heavy goods using the HMI system. The sensors attached to the user can monitor and transmit muscle signals to control the robot.
On the biomedical engineering side, doctors can remotely control robots to conduct surgery by wearing the HMI system with VR glasses. And medical workers can remotely manipulate the robot to look after infectious patients or collecting bio-samples, thus greatly decreasing the infection risk. The team conducted experiments to demonstrate the system's potential applications, such as remotely controlling the robotic hand to collect throat swab samples for COVID-19 tests, and to teleoperate humanoid robots to clean a room and even provide patient care. The team is developing a next-generation system to provide the robotic collection of swab tests. The researchers expect the new-generation HMI system to help provide a new approach in wirelessly connecting people to a robot or virtual character in the metaverse.
“This new-generation flexible human-machine interface system enables teleoperating robotics for conducting complicated tasks,” said Dr. Yu Xinge, Associate Professor in the Department of Biomedical Engineering (BME) at CityU.
Related Links:
City University of Hong Kong
Latest COVID-19 News
- New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
- Long COVID Etiologies Found in Acute Infection Blood Samples
- Novel Device Detects COVID-19 Antibodies in Five Minutes
- CRISPR-Powered COVID-19 Test Detects SARS-CoV-2 in 30 Minutes Using Gene Scissors
- Gut Microbiome Dysbiosis Linked to COVID-19
- Novel SARS CoV-2 Rapid Antigen Test Validated for Diagnostic Accuracy
- New COVID + Flu + R.S.V. Test to Help Prepare for `Tripledemic`
- AI Takes Guesswork Out Of Lateral Flow Testing
- Fastest Ever SARS-CoV-2 Antigen Test Designed for Non-Invasive COVID-19 Testing in Any Setting
- Rapid Antigen Tests Detect Omicron, Delta SARS-CoV-2 Variants
- Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study
- Set Up Reserve Lab Capacity Now for Faster Response to Next Pandemic, Say Researchers
- Blood Test Performed During Initial Infection Predicts Long COVID Risk
- Low-Cost COVID-19 Testing Platform Combines Sensitivity of PCR and Speed of Antigen Tests
- Finger-Prick Blood Test Identifies Immunity to COVID-19
- Quick Test Kit Determines Immunity Against COVID-19 and Its Variants
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more